FundedIQ
Biotechnology

NorthLinks Bio: Funding, Investors & Team (Oct 2026)

NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17, a intranasal antiviral designed to provide broad protection against respiratory viruses at the point of entry.Their simple, preventative approach has been shown to protect against influenza in a Phase 2 human challenge study.

www.northlinksbio.com LinkedIn Boston, United States 1-10 employees
Total raised
$34.0M
Rounds
1
Latest
Undisclosed round
Jun 2026

NorthLinks Bio has raised $34.0M across 1 funding round on record, the most recent an undisclosed round of $34.0M announced in Jun 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

NorthLinks Bio Company Profile and Key Stats

Total funding raised
$34.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$34.0M in Jun 2026
Employees
1-10
reported band
Headquarters
Boston, United States

Latest funding round on record: Jun 2026.

NorthLinks Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$34.0M

NorthLinks Bio Founders and Leadership Team

Name
Role
Contact
Fanny Cavalie
Founder
—

No contact details are on record for this team yet.

NorthLinks Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

NorthLinks Bio's latest round of $34.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like NorthLinks Bio in Biotechnology and Boston

Companies Similar to NorthLinks Bio

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

NorthLinks Bio Funding FAQs

What does NorthLinks Bio do?

NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17, a intranasal antiviral designed to provide broad protection against respiratory viruses at the point of entry.Their simple, preventative approach has been shown to protect against influenza in a Phase 2 human challenge study.

How much funding has NorthLinks Bio raised?

NorthLinks Bio has raised $34.0M across 1 round on record. The most recent is an undisclosed round of $34.0M announced in Jun 2026.

When did NorthLinks Bio last raise funding?

NorthLinks Bio's most recent funding round on record is an undisclosed round of $34.0M, announced in Jun 2026.

Who founded NorthLinks Bio?

FundedIQ lists Fanny Cavalie (Founder) at NorthLinks Bio.

Where is NorthLinks Bio headquartered?

NorthLinks Bio is based in Boston, Massachusetts, United States.

How many employees does NorthLinks Bio have?

NorthLinks Bio is in the 1-10 employee band.

How does NorthLinks Bio's funding compare to other Biotechnology startups?

NorthLinks Bio's latest round of $34.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's NorthLinks Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NorthLinks Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.